TMC Acquisitions recalls
TMC Acquisitions has 2 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 30 Aug 2023. The most frequent reason is sterility.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 30 Aug 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why tmc acquisitions is recalled
Product types
By year
All tmc acquisitions recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | NAD+ 200mg/ml vials, Tailor Made Compounding recalled | TMC Acquisitions | Sterility | Nationwide |
| Drug | CLASS II | Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials recalled | TMC Acquisitions | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.